Skip to main content
GLP-1 Receptor Agonists: Changing the Scales of Human Health

GLP-1 Receptor Agonists: Changing the Scales of Human Health


Presented by RGA

Glucagon-like peptide 1 receptor agonists (GLP-1s) may be poised to become an integral part of treating a range of chronic diseases – from cardiovascular disease to cancer – and could improve all-cause mortality rates.

Learn more >

Tags